Prof. Dr. Robert Wagner

Deputy Director, Senior Physician,
Department of Endocrinology and Diabetes,
University Hospital Düsseldorf (UKD)
Director of Clinical Studies Center,
German Diabetes Center (DDZ),
Leibniz Center for Diabetes Research at Heinrich-Heine-
University (HHU) Düsseldorf

PROFESSIONAL BACKGROUND

since 5/2022: Deputy Clinic Director, Department of Endocrinology and Diabetes, University Hospital Düsseldorf Director of Clinical Studies Center, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at HHU Düsseldorf
2021 – 2022: Director of Clinical Studies Center, Institute for Diabetes and Metabolic Research, University Hospital Tübingen
2019 – 2022: Senior Physician, Head of Endocrine University Outpatient Clinic, Medical University Hospital Tübingen
2010 – 2018: Specialist Physician and Research Fellow, Dept of Internal Medicine IV (Endocrinology, Diabetes, Nephrology), University Hospital Tübingen
2005 – 2010: Assistant Physician, Internal Medicine, Sigmaringen District Hospital, Academic Teaching Hospital of the University of Tübingen
2003 – 2005: Resident/Assistant Physician, Dept of Internal Medicine I, Semmelweis University, Budapest (Hungary)

EDUCATION

2019: Assistant Professor, Eberhard-Karls-University Tübingen
2018: Specialist Physician for Internal Medicine, Endocrinology and Diabetes
2017: Habilitation (venia legendi) für Innere Medizin, Eberhard-Karls-Universität Tübingen
2015: Diabetologist, German Diabetes Association (DDG)
2015: Doctor of Medicine (magna cum laude), Eberhard-Karls-University Tübingen
2009: Specialist Physician for Internal Medicine
2003: Doctor of Medicine, Semmelweis University Budapest
1997 – 2003: Study of Human Medicine, Semmelweis University, Budapest
1994 – 2000: Study of Economics (Economics and Business Administration), Focus: Economic Information Technology, MA Diploma, Budapest University of Economics (today: Corvinus University), Budapest

PREISE UND AUSZEICHNUNGEN

2022: Special Prize, Bytes4Diabetes Award
2021: Ferdinand-Bertram Prize, DDG
2021: Prevention Prize, German Society of Internal Medicine (DGIM)

SELECTED PUBLICATIONS

Yamazaki H, Tauchi S, Machann J, Haueise T, Yamamoto Y, Dohke M, Hanawa N, Kodama Y, Katanuma A, Stefan N, Fritsche A, Birkenfeld AL, Wagner R, Heni M (2022) Fat-distribution Patterns and Future Type-2 Diabetes Diabetes 20;db220315

Fritsche L, Heni M, Eckstein SS, Hummel J, Schürmann A, Häring HU, Preissl H, Birkenfeld AL, Peter A, Fritsche A, Wagner R (2022) Incretin Hypersecretion in Gestational Diabetes Mellitus J Clin Endocrinol Metab 17;107(6):e2425-30

Wagner R, Heni M, Tabák AG, Machann J, Schick F, Randrianarisoa E et al. (2021) Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes Nature Medicine 27(1):49-57

Dietz B, Machann J, Agrawal V, Heni M, Schwab P, Dienes J, Reichert S, Birkenfeld AL, Häring HU, Schick F, Stefan N, Fritsche A, Preissl H, Schölkopf B, Bauer S, Wagner R (2021) Diabetes detection from whole-body magnetic resonance imaging using deep learning JCI Insight 30;e146999

Wagner R, Eckstein SS, Yamazaki H, Gerst F, Machann J, Jaghutriz BA et al. (2021) Metabolic implications of pancreatic fat accumulation Nature Rev Endocrinol 20;1-12

Fritsche A, Wagner R, Heni M, Kantartzis K, Machann J, Schick F et al. (2021) Different effects of lifestyle intervention in high- and low-risk prediabetes Diabetes 16;db210526

Lamprinou A, Willmann C, Machann J, Schick F, Eckstein SS, Dalla Man C, Visentin R, Birkenfeld AL, Peter A, Stefan N, Häring HU, Fritsche A, Heni M, Wagner R (2021) Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study Metabolism 1;119:154776

Kullmann S, Valenta V, Wagner R, Tschritter O, Machann J, Häring HU et al. (2020) Brain insulin sensitivity is linked to adiposity and body fat distribution. Nature Communications 15;11(1):1841

Wagner R, Hakaste LH, Ahlqvist E, Heni M, Machann J, Schick F et al. (2017) Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance. Diabetes 1;66(5):1373-9

Wagner R, Kaiser G, Gerst F, Christiansen E, Due-Hansen ME, Grundmann M et al. (2013) Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans Diabetes 62(6):2106-11